Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

March 14, 2019

Study Completion Date

May 24, 2019

Conditions
Neonatal SEPSIS
Interventions
DRUG

Standard of Care + Fosfomycin

Fosfomycin will initially be administered IV for at least 48 hours together with standard care (ampicillin + gentamicin). Then, once babies are tolerating oral feeds and clinically improved, fosfomycin will be changed to oral administration to complete a total of 7 days of fosfomycin (or until the baby is discharged).

PROCEDURE

PK

Two PK samples will be taken after each of the first IV and oral doses, with sampling times allocated within possible early (5, 10 or 60 minutes) and late (2, 4 or 8 hours) time-points after starting the IV and PO formulations; then again together with biochemistry after 7 days for those babies whom remain as inpatients.

PROCEDURE

Analysis of Bacterial Isolates

For assessment of susceptibility patterns in bowel flora, we will systematically assess all admission and discharge nappy swabs.

Trial Locations (1)

80108

KEMRI / Wellcome Trust Research Programme, Kilifi

All Listed Sponsors
collaborator

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

collaborator

University of Oxford

OTHER

lead

Drugs for Neglected Diseases

OTHER

NCT03453177 - Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis | Biotech Hunter | Biotech Hunter